ABSTRACT
Background Community pharmacists play an important role as frontline health care workers during the COVID-19 pandemic. Therefore, the delivery of pharmaceutical care and the availability of drugs is compromised. The objective of this study was to evaluate the effect of coronavirus disease 2019 (COVID-19) on community pharmacy service delivery in Lagos state.
Methods A cross-sectional study with an online questionnaire created using Google Forms software was sent to community pharmacists in Lagos State, Nigeria via the Association of Community Pharmacists in Nigeria WhatsApp platforms. The sample size was 120 respondents conveniently chosen. Ethical approval was obtained from Health Research Ethics Committee, Lagos University Teaching Hospital (LUTH), Idi-Araba, Lagos State. Collected data was analyzed using Microsoft Excel.
Results A total of 125 respondents participated in the study. The result showed 56% were female respondents and the mean age of respondents was 32.4 ± 4.7 years. Measures such as the use of face masks (90.4%) and restricted number of patients for access at a time (89.6%) were implemented to reduce the spread of COVID-19. Majority of the respondents (61.6%) believe the measures have reduced the interaction between patients and pharmacists. Most of the respondents (81.6%) believe the pandemic has affected the availability and almost average (48%) of the respondents think that there was inflation in the prices of products like antimalarials, antibiotics, protective and preventive equipment and multivitamins.
Conclusion The COVID-19 pandemic has affected the delivery of pharmaceutical care to clients as well as the availability of medicines to patients. To improve the delivery of pharmaceutical care, tele-pharmacy and online pharmaceutical services may be employed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from Health Research Ethics Committee, Lagos University Teaching Hospital (LUTH), Idi-Araba, Lagos State
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
This version of the manuscript has been revised to update the author list and the author affiliations.
Data Availability
All data produced in the present work are contained in the manuscript
